Raynaud Phenomenon
Also known as: Raynaud’s phenomenon / Raynaud's Phenomenon / Raynaud’s syndrome / Raynaud's Syndrome / Raynaud Syndrome / Raynaud / Raynaud's Disease / Raynaud phenomenon / Raynauds / Raynaud Disease / Raynauds disease / Raynaud's phenomenon (disorder) / Secondary Raynaud's phenomenon (disorder) / Raynaud's disease (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00770 | Alprostadil | A prostaglandin E1 agonist used for the treatment of erectile dysfunction and as an adjunct for its diagnosis. |
DB01197 | Captopril | An ACE inhibitor used for the management of essential or renovascular hypertension, congestive heart failure, left ventricular dysfunction following myocardial infarction, and nephropathy. |
DB00568 | Cinnarizine | A drug used for the management of labyrinthine disorder symptoms, including vertigo, tinnitus, nystagmus, nausea, and vomiting. |
DB08941 | Isoxsuprine | A beta-adrenergic agonist used in the symptomatic treatment of cerebrovascular insufficiency, peripheral vascular disease of arteriosclerosis obliterans, thromboangiitis obliterans (Buerger's disease) and Raynaud's disease. |
DB01115 | Nifedipine | A dihydropyridine calcium channel blocker indicated for the management of several subtypes of angina pectoris, and hypertension. |
DB00457 | Prazosin | An alpha-blocker that causes a decrease in total peripheral resistance and is used to treat hypertension. |